A Clinical Trial of Anti-Angiogenic Drug Combination Tl-118 for Pancreatic Cancer Patients Who Are Starting Gemcitabine Treatment

Clinical trial NCT01509911 · UNKNOWN

Trial details

NCT number: NCT01509911
Sponsor: Tiltan Pharma Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Pancreatic Cancer

Start date: 2012-01-01
Primary completion: 2016-10-01
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.